Do good genes hold the key to a long life?

A genetic test that can predict whether a person is likely to live long enough to see their 100th birthday has been developed by scientists.

Researchers at Boston University in the United States claim the test can identify those who can look forward to an exceptionally long life with 77% accuracy. They designed the test after a major study into the genetic makeup of centenarians highlighted a host of DNA variants that boost a person’s chances of reaching a ripe old age.

Many of the genetic markers the scientists found stave off common, and often lethal, age-related diseases such as heart disease, dementia and high blood pressure. The US researchers investigated the genetic secrets of a longer life after studies showed that living beyond 100 often runs in families.

“These families might share healthy lifestyles, but it also suggests there is a strong genetic background to exceptional longevity,” said Professor Paola Sebastiani, a biostatistician at Boston University’s school for public health. Lifespan is governed by a complex interplay of genes, lifestyle and environment, with factors such as smoking, diet, exercise and pollution all having a role.

But many scientists believe living beyond the mid-90s is largely down to having good genes. Sebastiani and colleagues scanned the genomes of 1 055 centenarians and compared them with scans from 1 267 normal, healthy people. They found 150 DNA variants that were more common in the old-aged group and seemed to make their bodies healthier and more resilient.

The centenarians could be divided into 19 groups based on their genetic make-up. One of these groups was particularly resistant to age-related diseases and contained nearly half of all the centenarians that lived to 110 years or more. “There are particular combinations of these genetic variants that allow people to live not only a longer life, but also a healthier life. In centenarians, disability and disease tend to be delayed until the very end of their lives,” Sebastiani said.

The study, published in Science, will help researchers unravel why and how the body ages and could lead to drugs that can slow down the ageing process. “If we can pinpoint genetic variants that delay the onset of diseases, it could have very important medical implications for the population in general,” said Sebastiani.

One intriguing finding in the study was that gene variants that raise a person’s risk of disease may matter less than genes that protect against disease. The scientists found that centenarians had roughly the same number of highrisk genes as the rest of the population, but had more protective genes.

The finding is important, because commercial genetic tests look only for genes that raise a person’s disease risk, rather than reduce it. The study looked only at Caucasians, but Sebastiani said scientists should now look for DNA markers of longevity in other population groups.

Jeffrey Barrettt, an expert on disease genetics at the Wellcome Trust’s Sanger Institute in England, said the test might turn out to be less accurate when it is independently verified. “Some of the genetic variants in this study are claimed to have much, much stronger effects on longevity than we’ve seen in similar studies of diabetes, heart disease and cancer,” he said.

“For instance, the strongest single effect makes someone 10 times more likely than average to be extremely longlived, compared to other complex diseases where typical variants only make someone, say, one-and- a-half times as likely to be diabetic.

“Subtle biases in their work could contribute to these surprisingly large effects, which would make the test seem more accurate than it really is. Evaluation of the test by an independent laboratory will be the ultimate test of its accuracy,” Barrett said. —

These are unprecedented times, and the role of media to tell and record the story of South Africa as it develops is more important than ever. But it comes at a cost. Advertisers are cancelling campaigns, and our live events have come to an abrupt halt. Our income has been slashed.

The Mail & Guardian is a proud news publisher with roots stretching back 35 years. We’ve survived thanks to the support of our readers, we will need you to help us get through this.

To help us ensure another 35 future years of fiercely independent journalism, please subscribe.

Advertisting

Tension over who’s boss of courts

In a letter, Chief Justice Mogoeng Mogoeng questions whether Justice Minister Ronald Lamola has acted constitutionally

SABC sued over ‘bad’ clip of Ramaphosa

A senior employee at the public broadcaster wants compensation for claims of ‘sabotage’

Soundtrack to a pandemic: Africa’s best coronavirus songs

Drawing on lessons from Ebola, African artists are using music to convey public health messaging. And they are doing it in style

In East Africa, the locusts are coming back for more

In February the devastating locust swarms were the biggest seen in East Africa for 70 years. Now they’re even bigger

Press Releases

New energy mix on the cards

REI4P already has and will continue to yield thousands of employment opportunities

The online value of executive education in a Covid-19 world

Executive education courses further develop the skills of leaders in the workplace

Sisa Ntshona urges everyone to stay home, and consider travelling later

Sisa Ntshona has urged everyone to limit their movements in line with government’s request

SAB Zenzele’s special AGM postponed until further notice

An arrangement has been announced for shareholders and retailers to receive a 77.5% cash payout

20th Edition of the National Teaching Awards

Teachers are seldom recognised but they are indispensable to the country's education system

Awards affirm the vital work that teachers do

Government is committed to empowering South Africa’s teachers with skills, knowledge and techniques for a changing world

SAB Zenzele special AGM rescheduled to March 25 2020

New voting arrangements are being made to safeguard the health of shareholders